Table 2 Stem cell source, GVHD prophylaxis, and conditioning regimens
Haplo, n (%) | MUD 10/10, n (%) | p value | |
|---|---|---|---|
Stem cell source | |||
BM | 129 (52) | 167 (6) | < 10−4 |
PBSC | 121 (48) | 2422 (94) | |
Missing | 0 | 0 | |
GVHD prophylaxis | |||
Csa based | 4 (2) | 426 (17) | < 10−4 |
Csa + Mtx | 9 (4) | 656 (26) | |
Csa + Mmf ± others | 12 (5) | 1123 (44) | |
CSA + MMF ± MTX | 16 (7) | 29 (1) | |
Tacro alone | 1 (0) | 20 (1) | |
Mmf + Tacro/Mmf + Siro | 38 (16) | 185 (7) | |
Mtx + Tacro | 0 (0) | 44 (2) | |
Pt-Cy based | 156 (65) | 22 (1) | |
Others | 14 (1) | 84 (1) | |
In vivo TCD | |||
No | 181 (74) | 648 (25) | < 10−4 |
Yes | 63 (26) | 1915 (75) | |
Missing | 6 | 26 | |
Conditioning regimens | |||
MAC | 66 (27) | 591 (23) | 0.238 |
Bu-Cy/BuFlu | 7 | 253 | |
TBF | 31 | 8 | |
Flu-Mel | 7 | 81 | |
TBI based | 4 | 61 | |
Other | 17 | 188 | |
RIC | 182 (73) | 1948 (77) | |
Bu-Flu | 10 | 635 | |
TBF | 55 | 19 | |
Flu-Mel | 9 | 414 | |
TBI based | 55 | 457 | |
Other | 53 | 423 | |